Human medicines European public assessment report (EPAR): Lynozyfic, linvoseltamab, Date of authorisation: 23/04/2025, Status: Authorised
Human medicines European public assessment report (EPAR): Lynozyfic, linvoseltamab, Date of authorisation: 23/04/2025, Status: Authorised
Human medicines European public assessment report (EPAR): Lynozyfic, linvoseltamab, Date of authorisation: 23/04/2025, Status: Authorised
